EcoDrugPlus

Ensembl ID : ENSTNIG00000012574
Gene Symbol: -
1 Cross references
195 Possible Orthologues:

Ensembl ID : ENSTNIG00000013552
Gene Symbol: -
1 Cross references
213 Possible Orthologues:

Ensembl ID : ENSTNIG00000013553
Gene Symbol: -
1 Cross references
213 Possible Orthologues:

Ensembl ID : ENSTNIG00000013615
Gene Symbol: -
1 Cross references
216 Possible Orthologues:

Ensembl ID : ENSTNIG00000013769
Gene Symbol: -
1 Cross references
215 Possible Orthologues:

Ensembl ID : ENSTNIG00000013901
Gene Symbol: RPL24
2 Cross references
318 Possible Orthologues:

Ensembl ID : ENSTNIG00000014011
Gene Symbol: RPL23
2 Cross references
233 Possible Orthologues:

Ensembl ID : ENSTNIG00000014129
Gene Symbol: -
2 Cross references
213 Possible Orthologues:

Ensembl ID : ENSTNIG00000015118
Gene Symbol: -
1 Cross references
205 Possible Orthologues:

Ensembl ID : ENSTNIG00000015720
Gene Symbol: -
1 Cross references
230 Possible Orthologues:

Ensembl ID : ENSTNIG00000015783
Gene Symbol: -
1 Cross references
206 Possible Orthologues:

Ensembl ID : ENSTNIG00000017361
Gene Symbol: PLK4
2 Cross references
215 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).